Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics

Contact us

• Submission enquiries: bmccancer@biomedcentral.com
• General enquiries: ORSupport@springernature.com